BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2004
View Archived Issues
Novel somatostatin conjugate effective for treatment of choroidal neovascularization in vivo
Read More
Further data on antitumor activity of PEP-005 supporting use as topical anti-skin cancer agent
Read More
Prostanoid compound RUG-015 effectively reduces intraocular pressure
Read More
Enrollment closed in Gamunex trial for relapsing-remitting MS
Read More
Daiichi launches new Floxin Otic presentation
Read More
New findings support rapid onset of action of Levitra
Read More
Tularik reports first quarter developments
Read More
Spotlight on topiramate in the prevention of migraine
Read More
Pharmacokinetics and efficacy of ranibizumab in exudative AMD
Read More
Forbes Medi-Tech describes sterol-NSAID conjugates for cardiovascular disease and other uses
Read More
New mGluR5/mGluR1 antagonists presented by Euroceltique team
Read More
U. of Leiden researchers identify novel inhibitors of GST P1-1
Read More
Novel inhibitors of CDK2 and other kinases under study at Schering-Plough
Read More
3M scientists develop immune response modifiers for use in viral infections and cancer
Read More
Euroceltique claims new analgesic agents with VR1 and mGluR antagonist activity
Read More
Non-CNS penetrating mu opioid agonists covered by Euroceltique patent
Read More
Enrollment completed in phase III dalbavancin trials
Read More
Modified-release lercanidipine to be developed for Japanese market
Read More
Ranbaxy launches new strength of DisperMox
Read More
FDA approval for Enjuvia NDA
Read More
Phase I trial commences for oral CCR2 antagonist INCB-3284
Read More
Sonus completes private placement
Read More
Orbus acquires Midamor and Moduret in Canada
Read More
Partial clinical hold in phase IIa trial of HepeX-C
Read More
New low molecular weight compounds with anticancer and antibacterial activity
Read More
RNA-TEC and Lonza collaborate on TBDMS-based oligonucleotides
Read More
Private placement of BioSante common stock
Read More
Studies assess tacrolimus ointment in atopic dermatitis
Read More
ECCMID highlights: BAL-9141 not likely to induce resistance in MRSA
Read More
Good safety profile of DOV-216303 in healthy volunteers
Read More
Preclinical evidence for the efficacy of (S)-tofisopam in menopause and anxiety disorders
Read More
Novel PDF inhibitor BB-81384 shows good oral anti-pneumococcal activity and pharmacokinetics
Read More